IP Verse

Mavacamten For Use In The Treatment Of Hypertrophic Cardiomyopathy

Patent No. EP3661514 (titled "Mavacamten For Use In The Treatment Of Hypertrophic Cardiomyopathy") was filed by Myokardia on Aug 3, 2018. The application was issued on Sep 17, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KERNEBECK PATENTANWALTSJun 17, 2026KERNEBECK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3661514

MYOKARDIA
Application Number
EP18759209A
Filing Date
Aug 3, 2018
Status
Granted And Under Opposition
Aug 15, 2025
Publication Date
Sep 17, 2025
External Links
Slate, Register , Google Patents